NEWS
News Articles
Axion BioSystems Acquires Live-Cell Imaging Innovator CytoSMART Technologies
Maestro Pro CytoSMART Omni “Since Axion BioSystems’ inception, our focus has been on developing user-centric products that accelerate scientific discovery, with the specific goal of building innovative systems that monitor cellular activity without disturbing the underlying biology. The Maestro, our flagship bioelectronic assay (BEA) platform, has transformed neurological disease research over the past 14 years. Likewise, our…
Read MorePublic health professor awarded $600,000 NIH grant to study high-performing research organizations
Many scientific discoveries have transformed our lives and public health, and academia plays a significant role in the discovery process. Universities, and research institutions in particular, are eager to increase the flow of discoveries from life sciences research — but the how is less clear. To better understand the driving factors of quality research and…
Read MoreResearch in plant genomics is answering big biological questions
Buell’s research is contributing to breakthroughs in medicine, farming and energy production Since Robin Buell joined the University of Georgia faculty in fall 2021, there’s been a flurry of activity in her lab. Buell and her researchers have nine projects underway in plant genomics – and Buell has already secured millions of dollars in federal funding. This complex, very…
Read MoreGeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer, announced today that its Chairman & CEO, David Dodd, has been selected as a 2022 Georgia Titan 100. The Titan 100 program recognizes Georgia’s Top 100 CEOs & C-level executives. They represent the state’s most accomplished business leaders…
Read MoreThe Center for Global Health Innovation Announces Award of $9.8 Million Grant to Address Vaccine Hesitancy in 7 States
The Center for Global Health Innovation (CGHI) today announced the award of $9,850,664 from the Health Resources and Services Administration (HRSA) as part of the American Rescue Plan Act (ARPA) to fund the Center’s Vaccine Access and Training (VAT) initiative. “Public-private partnerships are essential to address public health crises at the community level. Our unique…
Read MoreEmory Alum to Lead Major Biotech Research Institute in Alabama
Dr. Neil Lamb to serve as President, Dr. Rick Myers to serve as Chief Scientific Officer HudsonAlpha Institute for Biotechnology announced today that NeilLamb, PhD, current Vice President for Educational Outreach, will be the new President of theInstitute effective July 1, 2022, as rapid economic growth and advancements in genomics andlife science research have driven…
Read More